Test Bank - Karch Focus on Nursing Pharmacology 9th
| | | | | | | |
Edition by Rebecca Tucker
| | | | |
Chapters 1 - 59 | | | |
, Table of Contents | |
Chapter |01- |Introduction |to |Drugs
|Chapter |02- |Drugs |and |the |Body
|Chapter |03- |Toxic |Effects |of |Drugs
Chapter |04- |The |Nursing |Process |in |Drug |Therapy |and |Patient |Safety
|Chapter |05- |Dosage |Calculations
Chapter |06- |Challenges |to |Effective |Drug |Therapy
|Chapter |07- |Introduction |to |Cell |Physiology
|Chapter |08- |Anti-infective |Agents
Chapter |09- |Antibiotics
|Chapter |10- |Antiviral |Agents
|Chapter |11- |Antifungal |Agents
Chapter |12- |Antiprotozoal |Agents
|Chapter |13- |Anthelmintic |Agents
|Chapter |14- |Antineoplastic
|Agents
Chapter |15- |Introduction |to |the |Immune |Response |and |Inflammation
|Chapter |16- |Anti-inflammatory, |Antiarthritis, |and |Related |Agents
|Chapter |17- |Immune |Modulators
Chapter |18- |Vaccines |and |Sera
Chapter |19- |Introduction |to |Nerves |and |the |Nervous |System
|Chapter |20- |Anxiolytic |and |Hypnotic |Agents
Chapter |21- |Antidepressant |Agents
|Chapter |22- |Psychotherapeutic
|Agents|Chapter |23- |Antiseizure
|Agents |Chapter |24- |Antiparkinsonism
|Agents|Chapter |25- |Muscle |Relaxants
Chapter |26- |Narcotics, |Narcotic |Antagonists, |and |Antimigraine |Agents
|Chapter |27- |General |and |Local |Anesthetic |Agents
Chapter |28- |Neuromuscular |Junction |Blocking |Agents
|Chapter |29- |Introduction |to |the |Autonomic |Nervous |System
|Chapter |30- |Adrenergic |Agonists
Chapter |31- |Adrenergic |Antagonists
|Chapter |32- |Cholinergic |Agonists
|Chapter |33- |Anticholinergic |Agents
Chapter |34- |Introduction |to |the |Endocrine |System
|Chapter |35- |Hypothalamic |and |Pituitary |Agents
|Chapter |36- |Adrenocortical |Agents
Chapter | 37- | Thyroid | and |Parathyroid | Agents
|Chapter |38- |Agents |to |Control |Blood |Glucose |Levels
|Chapter |39- |Introduction |to |the |Reproductive |System
Chapter |40- |Drugs |Affecting |the |Female |Reproductive |System
|Chapter |41- |Drugs |Affecting |the |Male |Reproductive |System
|Chapter |42- |Introduction |to |the |Cardiovascular |System
|Chapter |43- |Drugs |Affecting |Blood |Pressure
Chapter |44- |Agents |for |Treating |Heart |Failure
|Chapter |45- |Antiarrhythmic |Agents
Chapter |46- |Antianginal |Agents
|Chapter |47- |Lipid-Lowering |Agents
Chapter |48- |Drugs |Affecting |Blood |Coagulation
|Chapter |49- |Drugs |Used |to |Treat |Anemias
|Chapter |50- |Introduction |to |the |Renal |System
|Chapter |51- |Diuretic |Agents
Chapter |52- |Drugs |Affecting |the |Urinary |Tract |and |the |Bladder
|Chapter |53- |Introduction |to |the |Respiratory |System
Chapter |54- |Drugs |Acting |on |the |Upper |Respiratory |Tract
|Chapter |55- |Drugs |Acting |on |the |Lower |Respiratory |Tract
|Chapter |56- |Introduction |to |the |Gastrointestinal |System
|Chapter |57- |Drugs |Affecting |Gastrointestinal |Secretions
|Chapter |58- |Drugs |Affecting |Gastrointestinal |Motility
|Chapter |59- |Antiemetic | Agents
, Chapter |1: |Introduction |to |Drugs
Cognitive |Level: | Application
Difficulty: |Moderate
|
Integrated |Process: | Nursing |process
1.A |nurse |working |in |radiology |administers |iodine |to |a |patient |who |is |having |a
computerized |axial |tomography |(CAT) |scan. |A |nurse |working |on |an |oncology |unit
|
administers |chemotherapy |to |patients |who |have |cancer. |At |the |Public |Health
|
Department, |a |nurse |administers |a |measles-mumps-rubella |(MMR) |vaccine |to |a |14-
|
month-old |child |as |a |routine |immunization. |Which |branch |of |pharmacology |best
|
describes |the |actions |of |all |three |nurses?
|
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Response:
Pharmacology |is |the |study |of |the |biologic |effects |of |chemicals. |Nurses |are |involved
with |clinical |pharmacology |or |pharmacotherapeutics, |which |is |a |branch |of
|
pharmacology |that |deals |with |the |uses |of |drugs |to |treat, |prevent, |and |diagnose |disease.
|
The |nurse |working |in |radiology |is |administering |a |drug |to |help |diagnose |a |disease. |The
|
nurse |working |on |an |oncology |unit |is |administering |a |drug |to |help |treat |a|disease.
|
Pharmacoeconomics |includes |any |costs |involved |in |drug |therapy.
|
Pharmacodynamics |involves |how |a |drug |affects |the |body, |and |pharmacokinetics |is
how |the |body |acts |on |the |drug.
|
Cognitive |Level: |Comprehension
Difficulty: |Easy
|
Integrated |Process: | Nursing |process
2.A |physician |has |ordered |intramuscular |injections |of |morphine, |a |narcotic, |every |4
hours |as |needed |for |pain |for |a |motor |vehicle |accident |victim. |The |nurse |is |aware |that
|
there |is |a |high |abuse |potential |for |this |drug; |therefore, |morphine |is |categorized |as |a:
|
A) Schedule |I |drug
B) Schedule |II |drug
C) Schedule |III |drug
D) Schedule |IV |drug
, ANSWER: B
Response:
Narcotics |such |as |morphine |are |considered |schedule |II |drugs |because |of |the |high |abuse
potential |with |severe |dependence |liability. |Schedule |I |drugs |have |high |abuse |potential
|
and |no |accepted |medical |use. |Schedule |III |drugs |have |a |lesser |abuse |potential |than
|
schedule |II |drugs |and |an |accepted |medical |use. |Schedule |IV |drugs |have|low |abuse
|
potential |and |limited |dependence |liability.
|
Cognitive |Level: |Comprehension
Difficulty: |Easy
|
Integrated |Process: | Communication |and |documentation
3.A |nurse |working |for |a |drug |company |is |involved |in |phase |III |drug |evaluation |studies.
Which |of |the |following |might |the |nurse |be |responsible |for |during |this |stage |of |drug
|
development?
|
| | | | | | | |
Edition by Rebecca Tucker
| | | | |
Chapters 1 - 59 | | | |
, Table of Contents | |
Chapter |01- |Introduction |to |Drugs
|Chapter |02- |Drugs |and |the |Body
|Chapter |03- |Toxic |Effects |of |Drugs
Chapter |04- |The |Nursing |Process |in |Drug |Therapy |and |Patient |Safety
|Chapter |05- |Dosage |Calculations
Chapter |06- |Challenges |to |Effective |Drug |Therapy
|Chapter |07- |Introduction |to |Cell |Physiology
|Chapter |08- |Anti-infective |Agents
Chapter |09- |Antibiotics
|Chapter |10- |Antiviral |Agents
|Chapter |11- |Antifungal |Agents
Chapter |12- |Antiprotozoal |Agents
|Chapter |13- |Anthelmintic |Agents
|Chapter |14- |Antineoplastic
|Agents
Chapter |15- |Introduction |to |the |Immune |Response |and |Inflammation
|Chapter |16- |Anti-inflammatory, |Antiarthritis, |and |Related |Agents
|Chapter |17- |Immune |Modulators
Chapter |18- |Vaccines |and |Sera
Chapter |19- |Introduction |to |Nerves |and |the |Nervous |System
|Chapter |20- |Anxiolytic |and |Hypnotic |Agents
Chapter |21- |Antidepressant |Agents
|Chapter |22- |Psychotherapeutic
|Agents|Chapter |23- |Antiseizure
|Agents |Chapter |24- |Antiparkinsonism
|Agents|Chapter |25- |Muscle |Relaxants
Chapter |26- |Narcotics, |Narcotic |Antagonists, |and |Antimigraine |Agents
|Chapter |27- |General |and |Local |Anesthetic |Agents
Chapter |28- |Neuromuscular |Junction |Blocking |Agents
|Chapter |29- |Introduction |to |the |Autonomic |Nervous |System
|Chapter |30- |Adrenergic |Agonists
Chapter |31- |Adrenergic |Antagonists
|Chapter |32- |Cholinergic |Agonists
|Chapter |33- |Anticholinergic |Agents
Chapter |34- |Introduction |to |the |Endocrine |System
|Chapter |35- |Hypothalamic |and |Pituitary |Agents
|Chapter |36- |Adrenocortical |Agents
Chapter | 37- | Thyroid | and |Parathyroid | Agents
|Chapter |38- |Agents |to |Control |Blood |Glucose |Levels
|Chapter |39- |Introduction |to |the |Reproductive |System
Chapter |40- |Drugs |Affecting |the |Female |Reproductive |System
|Chapter |41- |Drugs |Affecting |the |Male |Reproductive |System
|Chapter |42- |Introduction |to |the |Cardiovascular |System
|Chapter |43- |Drugs |Affecting |Blood |Pressure
Chapter |44- |Agents |for |Treating |Heart |Failure
|Chapter |45- |Antiarrhythmic |Agents
Chapter |46- |Antianginal |Agents
|Chapter |47- |Lipid-Lowering |Agents
Chapter |48- |Drugs |Affecting |Blood |Coagulation
|Chapter |49- |Drugs |Used |to |Treat |Anemias
|Chapter |50- |Introduction |to |the |Renal |System
|Chapter |51- |Diuretic |Agents
Chapter |52- |Drugs |Affecting |the |Urinary |Tract |and |the |Bladder
|Chapter |53- |Introduction |to |the |Respiratory |System
Chapter |54- |Drugs |Acting |on |the |Upper |Respiratory |Tract
|Chapter |55- |Drugs |Acting |on |the |Lower |Respiratory |Tract
|Chapter |56- |Introduction |to |the |Gastrointestinal |System
|Chapter |57- |Drugs |Affecting |Gastrointestinal |Secretions
|Chapter |58- |Drugs |Affecting |Gastrointestinal |Motility
|Chapter |59- |Antiemetic | Agents
, Chapter |1: |Introduction |to |Drugs
Cognitive |Level: | Application
Difficulty: |Moderate
|
Integrated |Process: | Nursing |process
1.A |nurse |working |in |radiology |administers |iodine |to |a |patient |who |is |having |a
computerized |axial |tomography |(CAT) |scan. |A |nurse |working |on |an |oncology |unit
|
administers |chemotherapy |to |patients |who |have |cancer. |At |the |Public |Health
|
Department, |a |nurse |administers |a |measles-mumps-rubella |(MMR) |vaccine |to |a |14-
|
month-old |child |as |a |routine |immunization. |Which |branch |of |pharmacology |best
|
describes |the |actions |of |all |three |nurses?
|
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Response:
Pharmacology |is |the |study |of |the |biologic |effects |of |chemicals. |Nurses |are |involved
with |clinical |pharmacology |or |pharmacotherapeutics, |which |is |a |branch |of
|
pharmacology |that |deals |with |the |uses |of |drugs |to |treat, |prevent, |and |diagnose |disease.
|
The |nurse |working |in |radiology |is |administering |a |drug |to |help |diagnose |a |disease. |The
|
nurse |working |on |an |oncology |unit |is |administering |a |drug |to |help |treat |a|disease.
|
Pharmacoeconomics |includes |any |costs |involved |in |drug |therapy.
|
Pharmacodynamics |involves |how |a |drug |affects |the |body, |and |pharmacokinetics |is
how |the |body |acts |on |the |drug.
|
Cognitive |Level: |Comprehension
Difficulty: |Easy
|
Integrated |Process: | Nursing |process
2.A |physician |has |ordered |intramuscular |injections |of |morphine, |a |narcotic, |every |4
hours |as |needed |for |pain |for |a |motor |vehicle |accident |victim. |The |nurse |is |aware |that
|
there |is |a |high |abuse |potential |for |this |drug; |therefore, |morphine |is |categorized |as |a:
|
A) Schedule |I |drug
B) Schedule |II |drug
C) Schedule |III |drug
D) Schedule |IV |drug
, ANSWER: B
Response:
Narcotics |such |as |morphine |are |considered |schedule |II |drugs |because |of |the |high |abuse
potential |with |severe |dependence |liability. |Schedule |I |drugs |have |high |abuse |potential
|
and |no |accepted |medical |use. |Schedule |III |drugs |have |a |lesser |abuse |potential |than
|
schedule |II |drugs |and |an |accepted |medical |use. |Schedule |IV |drugs |have|low |abuse
|
potential |and |limited |dependence |liability.
|
Cognitive |Level: |Comprehension
Difficulty: |Easy
|
Integrated |Process: | Communication |and |documentation
3.A |nurse |working |for |a |drug |company |is |involved |in |phase |III |drug |evaluation |studies.
Which |of |the |following |might |the |nurse |be |responsible |for |during |this |stage |of |drug
|
development?
|
